About prostate cancer
Prostate cancer is the most common male malignancy (except for non-melanoma skin tumours). Nearly 8,000 men get prostate cancer every year, three times more than 20 years ago. The higher incidence of prostate cancer is explained by both the population ageing and the increase in routine prostate-specific antigen (PSA) screening in older men. As a result, early-stage cancers, which are still clinically silent and would not have manifested otherwise, are more frequently detected. Approximately 1,500 men die from this cancer each year and there are currently more than 70,000 men in the Czech population with a history of this disease.
Prostate cancer is the most common malignant tumour in men. Diagnosis of the cancer occurs in the 6th and 7th decade of life, but detection is also shifting to younger ages. Current international recommendations tend to suggest that individualised early detection may be beneficial, whereas grey screening may lead to lower efficacy and safety of the process.
*For 2020 this is preliminary data, at the time of processing the data is still being reconciled with the provider.
Download the invitation in PDF format here
Download the program in PDF format here